Precision Robotics (Hong Kong) Limited Partners with Gleneagles Hospital Hong Kong to Enhance Surgical Robotic Innovations

(HONG KONG – February 1, 2023) – Precision Robotics (Hong Kong) Limited (PRHK), a partner company of Hong Kong Science and Technology Parks Corporation (HKSTP) and a leading surgical robotics company, today signed a high-level Memorandum of Understanding (MOU) with Gleneagles Hospital Hong Kong (Gleneagles), its longstanding clinical partner and a multispecialty private hospital, at Park Lane, a Pullman Hotel in Hong Kong. The MOU will strengthen their collaborative partnership to work towards a common goal: improving patient care and nurturing technological advances in healthcare and fostering innovation in Hong Kong.

PRHK and Gleneagles have enjoyed a long-standing friendship, and this MOU strengthens and harmonizes the partnership. In this three-year consortium, each party will synergistically work on various significant activities facilitating the effective exchange of scientific knowledge gained from clinical validation studies of the latest surgical robots developed by PRHK, promoting development, and fostering novel technological innovations, transforming human-assisted surgery into automated precision solutions, which ultimately promises to improve patient quality of life.

The MOU was signed by Dr. Benny Lo, CEO of PRHK & Dr. Kenneth Tsang, CEO of Gleneagles, in the presence of Professor Dong  Sun, JP, Secretary for Innovation, Technology and Industry; Professor Guang-Zhong Yang, Founder, and Chairman of PRHK; Professor Andrew Young, Chairman of Hong Kong Automation Technology Council and Associate Director (Innovation) of Sino Group; and Dr. Tong Yow Ng, Director of Peritoneal Malignancy Treatment Centre at Gleneagles.

“We are delighted to have our honourable guests Professor Dong Sun as well as Dr. Sunny Chai and Mr. Albert Wong of the Hong Kong Science and Technology Parks Corporation witnessing this very important milestone of PRHK today. I would also like to thank Dr. Kenneth Tsang for his support and leadership in making this significant collaboration possible,” PRHK’s Founder, Professor Guang-Zhong Yang, said. 

“PRHK is laser-focused on innovation in surgical technologies promising to advance the patient care in Hong Kong and the Greater Bay Area. Thanks Professor Dong Sun and the Hong Kong Government’s support to high tech start-up companies, like PRHK, through its funding schemes, such as the Enterprise Support Scheme, coupled with the advanced facilities provided in the Science Park, we are able to further strengthen our medical and surgical systems and nurture professional talents. I look forward to enhancing surgical robot applications to patients through our partnership with Gleneagles Hospital well-trained and outstanding medical team.”

Dr. Kenneth Tsang, CEO of Gleneagles, remarked that the partnership provides PRHK and Gleneagles with a strategic platform to foster the development of technological innovations in healthcare. "Leveraging PRHK's top-notch expertise in surgical robot development and application, we look forward to helping to turn our joint clinical research effort into healthcare solutions that will bring better care, higher precision, and more advanced options to patients."

SIRIUS Endoscope System Received FDA Clearance

Dec 2022, PRHK’s flagship product, SIRIUS Endoscope System, received 510k clearance by the United States Food and Drug Administration (FDA), which means it is proven to be safe and effective in its intended use and has attained world-class quality standards.

Dr. Benny Lo, CEO of PRHK, pointed out, “The FDA 510K clearance and the clinical data obtained through the collaboration with Gleneagles will enable PRHK to further promote its medical robotics technology in Hong Kong and the Asia Pacific region. PRHK's position as a leading protagonist in the development of innovative solutions for surgical robotics will also be strengthened.”

PRHK is a portfolio company of Hong Kong Science and Technology Parks Corporation (HKSTP) Venture Fund, a fund which invests in promising tech ventures as well as help them attract private capital. The Hong Kong Science Park is home to over 1,200 innovation and technology companies such as PRHK in fields including artificial intelligence, robotics, biomedical technology and more.

Mr. Albert Wong, CEO of HKSTP, said, “We are proud of Precision Robotics, who have been a longstanding part of our ecosystem and a good example of how with the right support, research can translate into scalable commercial success. This collaboration is a significant milestone in their mission to advance the application of robotics in healthcare and we are pleased to see them continue to grow from strength to strength.”

PRHK strives to transform the field of minimally invasive surgery with its ground-breaking articulated camera system, enabling advanced laparoscopic surgeries with precision, accuracy, and reliability. With Gleneagles’ expertise, clinical excellence, and state-of-the-art facilities, PRHK will continue to enhance surgical robot applications for both surgeons and patients.